Cases of norovirus infections are surging, but coming up with a way to prevent them has proven to be a challenge.

P eter Hotez has made every effort to stay up to date with Covid-19 vaccines, starting with the initial two doses and ...

While the headline numbers don't inspire much confidence, Moderna is a stock that deserves a closer look. The company still ...

Stock-plunging mRNA vaccine maker, already in bed with feds on vaccine royalties, says booster not "causally" related without ...

Big news in health: The Food and Drug Administration has approved new COVID-19 vaccines from Pfizer and Moderna. The updated ...

Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.

The Department of Health Services has awarded $590 million to Moderna to speed up the development of flu vaccines, including ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.

The public health risk remains low, but bird flu variants have proven to be unpredictable, which is why the virus is a top ...

All new Pfizer and Moderna vaccines target the Omicron variant KP ... In the future, we may even need two or more booster doses per year, says Dr. Priya Sampathkumar, an infectious disease ...

Moderna slashed its 2025 revenue projection by $1bn on Monday, citing reduced demand for its Covid-19 and respiratory ...